logo
#

Latest news with #ELV

Elevance Health CEO Boudreaux buys $2.44M of shares
Elevance Health CEO Boudreaux buys $2.44M of shares

Business Insider

timea day ago

  • Business
  • Business Insider

Elevance Health CEO Boudreaux buys $2.44M of shares

Elevance Health (ELV) CEO Gail Boudreaux disclosed the purchase of 8,500 shares at an average price of $286.94 for total value of $2.44M. Boudreaux now owns 151,020 shares of Elevance. Shares of Elevance bounced off their lows but remain down 6% to $283.52 in afternoon trading. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.

Bernstein Calls UnitedHealth Stock (UNH) a Top Pick Ahead of Q2 Earnings
Bernstein Calls UnitedHealth Stock (UNH) a Top Pick Ahead of Q2 Earnings

Business Insider

time2 days ago

  • Business
  • Business Insider

Bernstein Calls UnitedHealth Stock (UNH) a Top Pick Ahead of Q2 Earnings

UnitedHealth Group (UNH) stock has plunged about 42% year-to-date, due to higher costs, primarily in the Medicare Advantage (MA) segment, an abrupt CEO exit, the withdrawal of the full-year guidance, and the Department of Justice's (DOJ) probe into the company's Medicare billing practices. Ahead of the upcoming Q2 earnings on July 29, Bernstein called UNH a Top Pick, noting that the pullback in the stock due to the ongoing pressures has created a 'very attractive entry point.' Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Wall Street expects UnitedHealth to report earnings per share (EPS) of $4.88 for Q2 2025, reflecting a more than 31% year-over-year decline. Bernstein Is Bullish on UNH Stock Bernstein analyst Lance Wilkes expects UNH to benefit from a 'hardening' pricing market for government Managed Care Organizations (MCOs) and utilization decelerating back to normal levels. Wilkes lowered his 2025 EPS estimate by 10% to reflect reserve strengthening, cost pressures in Individual and Medicaid businesses, and 'clean-up of OptumHealth risk contracts for less engaged physician practices.' Wilkes expects a doubling of EPS from 2025 to 2029 at a compound annual growth rate (CAGR) of 19%, driven by sector recovery and company-specific margin recovery, while accounting for slower growth rates in UHC MA (UnitedHealthcare Medicare Advantage) and OptumHealth. Further, the analyst stated that COVID-induced Medicare cycles drove margins to trough levels, and he expects normalization to begin in the third quarter in Medicaid and in the first quarter of 2026 in MA. Wilkes contends that at the current P/E (price-to-earnings) of 13.5x, UNH stock is trading at a 'very attractive entry point.' Aside from UNH, the analyst also named Elevance Health (ELV) stock as a Top Pick. However, he noted that while ELV has similar exposures as UNH due to its diversified model, the Medicaid exposure is greater, which increases policy-related uncertainty. The analyst emphasized that the relative P/Es remain 'significantly depressed,' with UNH and ELV stocks down 50% to 60% from pre-COVID levels. He believes that these low valuation levels, which are below the relative P/E levels over the past decade, present a unique opportunity to buy UNH and ELV stocks. What Is the Price Target for UNH Stock? Wall Street has a Moderate Buy consensus rating on UnitedHealth stock based on 18 Buys, seven Holds, and one Sell recommendation. The average UNH stock price target of $355.74 indicates 21.6% upside potential.

Elevance Health (ELV) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Elevance Health (ELV) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Yahoo

time3 days ago

  • Business
  • Yahoo

Elevance Health (ELV) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended June 2025, Elevance Health (ELV) reported revenue of $49.42 billion, up 14.3% over the same period last year. EPS came in at $8.84, compared to $10.12 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $48.15 billion, representing a surprise of +2.64%. The company delivered an EPS surprise of -3.49%, with the consensus EPS estimate being $9.16. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how Elevance Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Benefit Expense Ratio: 88.9% versus the 16-analyst average estimate of 88.4%. Medical Membership - Commercial Risk-Based: 4.96 million versus 5 million estimated by 15 analysts on average. Medical Membership - Commercial Fee-Based: 27.15 million versus 27.22 million estimated by 15 analysts on average. Medical Membership - Commercial Risk-Based - Individual: 1.35 million versus 1.36 million estimated by 15 analysts on average. Revenues- Service fees: $2.11 billion compared to the $2.23 billion average estimate based on 16 analysts. The reported number represents a change of -7.4% year over year. Revenues- Product revenue: $6.04 billion versus $6.14 billion estimated by 16 analysts on average. Compared to the year-ago quarter, this number represents a +9.3% change. Revenues- Net investment income: $486 million versus $464.67 million estimated by 16 analysts on average. Compared to the year-ago quarter, this number represents a -4.3% change. Revenues- Premiums: $41.27 billion versus the 16-analyst average estimate of $39.64 billion. The reported number represents a year-over-year change of +16.5%. Total operating revenue- Health Benefits: $41.58 billion versus the 15-analyst average estimate of $40.84 billion. The reported number represents a year-over-year change of +11.9%. Total operating revenue- Carelon: $18.08 billion versus $16.86 billion estimated by 15 analysts on average. Compared to the year-ago quarter, this number represents a +35.8% change. Total operating revenue- Carelon Services: $7.44 billion versus $6.8 billion estimated by 15 analysts on average. Compared to the year-ago quarter, this number represents a +63.7% change. Total operating revenue- CarelonRx: $10.64 billion versus $10.05 billion estimated by 15 analysts on average. Compared to the year-ago quarter, this number represents a +21.3% change. View all Key Company Metrics for Elevance Health here>>> Shares of Elevance Health have returned -8.3% over the past month versus the Zacks S&P 500 composite's +4.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Elevance Health, Inc. (ELV) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research

DPCC launches innovation challenge to reduce emissions from overage vehicles
DPCC launches innovation challenge to reduce emissions from overage vehicles

Time of India

time3 days ago

  • Automotive
  • Time of India

DPCC launches innovation challenge to reduce emissions from overage vehicles

New Delhi: The Delhi Pollution Control Committee (DPCC) will launch an innovation challenge focusing on identifying and promoting low-cost, easy-to-maintain and effective technological solutions capable of reducing or absorbing PM2.5 and PM10 emissions (at least twice the amount emitted) from End-of-Life Vehicles (ELVs) operating within the territory of Delhi. A standing order was issued by the environment minister, Manjinder Singh Sirsa, to the DPCC on Thursday in this regard. The order stated that the proposed technologies or devices may be fitted inside or externally on the vehicle and be designed to neutralise, capture or offset PM2.5 and PM10 pollutants beyond the levels emitted by the ELV. The solutions should emphasise affordability for end-users, ease of installation and maintenance, scalability and real-world feasibility. "The challenge shall be launched within 30 days from the issue of this order, followed by evaluation and declaration of results within 90 days of launch," the order said. You Can Also Check: Delhi AQI | Weather in Delhi | Bank Holidays in Delhi | Public Holidays in Delhi The challenge will be open to individuals, startups, research institutions and technology developers across India. To select the technologies, an independent panel of technical experts should be constituted for the purpose of evaluating the submissions. "A premier technical institute such as the Indian Institute of Technology (IIT) Delhi shall be formally requested to lead this technical committee and participate in the evaluation and selection process. The panel may also include representatives from environmental engineering institutes, automotive sector experts and members from the DPCC," said the order. The order stated that the final report outlining the submissions received, the evaluation methodology and recommended solutions will be shared with the govt for final approval. "DPCC has been asked to show a formal outline of the project, including a problem statement, within five days from the issuance of this order." The environment minister said, "Reducing vehicular pollution in Delhi is a challenge for us. Delhi govt is exploring all options to reduce vehicular pollution."

‘Scrapped — but still running': Overage vehicle owners cry foul, Delhi govt to probe
‘Scrapped — but still running': Overage vehicle owners cry foul, Delhi govt to probe

Indian Express

time4 days ago

  • Automotive
  • Indian Express

‘Scrapped — but still running': Overage vehicle owners cry foul, Delhi govt to probe

After receiving several complaints from owners of end-of-life vehicles, the BJP Delhi government is set to initiate a probe into registered vehicle scrapping facilities (RVSFs) involved in impounding ELVs, said officials. Environment Minister Manjinder Singh Sirsa said he would soon order a probe into the matter. The inquiry is set to investigate possible lapses, mismanagement, and irregularities by RVSFs in seizing, scrapping, and releasing vehicles, said an official, adding that departments involved in the drive, like the Transport department, the Traffic Police, and the MCD, will be asked to submit a detailed report. According to officials, ELV owners have complained to the Transport department that RVSFs authorised by it to seize and scrap overaged vehicles charged vehicle owners extra money for towing, handling, and logistical charges. 'Many also alleged they did not receive the scrap value on time and their vehicles were not released by the RVSFs, despite receiving the department's permission to do so. Further, we have observed that even if the vehicle owners were paid, they received reduced scrap value after deductions for towing and parking charges, in violation of guidelines,' said a senior official. Moreover, officials said, many have complained that the RVSFs were not providing the Certificate of Deposit (COD) to vehicle owners on time and 'were generating wrong COD… and trading it without owner consent'. 'As per ELV guidelines, the COD and Certificate of Vehicle Scrapping (CVS) are issued to those who get their ELVs scrapped from a RVSF… The owners can show the COD to get a discount on purchasing a new vehicle. But the scrappers have been trading by selling CODs illegally…,' said the senior official. Under the discount scheme, while the concession is 20% for new non-transport petrol/ CNG/LPG vehicles and 15% for diesel vehicles, for transport vehicles, the concession is 15% for petrol/CNG/LPG and 10% for diesel. However, tax concessions cannot exceed 50% of the scrap value. Also, the COD is only valid for three years from the date of issuance. Further, no concessions will be available for government-owned or impounded vehicles, according to norms. 'Also, while RVSFs show in their records that vehicles have been scrapped, in reality, they sell these vehicles in other states illegally… Many people have said they have received messages about vehicles with their numbers paying toll tax in different states,' the official added. Officials said if the people do not claim their vehicles from RVSFs in 15 days, the RVSFs are to deposit the scrap value into the government's treasury. But this has not been done. The Transport department, a few months ago, had issued showcause notices to 11 authorised RVSFs in this regard, said officials. It had also asked all the RVSFs to deposit the full scrap value in the government treasury. 'The scrappers are yet to submit the money. There are huge gaps… these scrappers also do not conduct audits and keep records as per guidelines for handling ELVs,' said an official. The Transport department had first launched an aggressive drive against overaged petrol and diesel vehicles in March 2023. However, after several vehicle owners moved court against the drive, the court directed the department to come up with a policy for the scrapping and handling of these vehicles. While last year, 39,273 vehicles were scrapped, the figure was 22,397 in 2023, said officials.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store